Low-Quality IV Fluids bottles seized at SKIMS

4,400 bottles of intravenous fluids including Normal Saline (NS), Dextrose (DS), Ringer Lactate (RL) and Sodium Chloride (SC) seized during raids at the pharmacy department stores at Sher-i-Kashmir Institute of Medical Sciences (SKIMS) Soura. A team of inspectors from the Drug and Food Control Organisation (DFCO) raided pharmacy stores after receiving a tip and seized poor quality bottles of IV fluids in the raid. IV Fluids are mainly used to treat dehydration.

DFCO said that the administration of SKIMS Soura had violated the Drug and Cosmetic Act by supplying “poor quality” intravenous fluids to thousands of patients. The team collected the samples of all categories of drugs for detailed examination so that prosecution can be initiated against SKIMS officials.

DFCO will also be going to file a case against SKIMS officials after the test reports come from the labs. Irfana Ahmad, Deputy Drug Controller of the DFCO said that we acted after receiving a complaint from some of the city doctors regarding the “poor quality” of IV fluids in the drug stores of SKIMS Soura.

The issue is serious as it relates to the health of the people of Kashmir. DFCO officer also said that the SKIMS pharmacy department was under their scanner for a long time after receiving several complaints in the past. DFCO acted previously for the past complaints and found many violations. SKIMS drug dispensation comes under DFCO jurisdiction as per the Drug Act, so DFCO closely monitoring it.

Related Posts

Lilly launches Mounjaro KwikPen in India

Mumbai, August 14, 2025 — Eli Lilly and Company (India) has rolled out the Mounjaro (tirzepatide) KwikPen across the country, expanding treatment choices for people with type-2 diabetes and those…

Fortis Q1 Profit Jumps 57%; Expansion Drives Growth

  Gurugram, August 7 – http://Fortis HealthcareFortis Healthcare has reported a 57% year-on-year increase in its net profit for the first quarter of FY2025. The hospital chain posted ₹260 crore…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Aurobindo Pharma Rs 800 Cr Buyback Opens Apr 23

Aurobindo Pharma Rs 800 Cr Buyback Opens Apr 23

Boehringer Ingelheim launches AI centre for pharma research in London

Boehringer Ingelheim launches AI centre for pharma research in London

Pharma exports rose 2% to over $31 billion in FY26 despite sharp decline in March

Pharma exports rose 2% to over $31 billion in FY26 despite sharp decline in March

Centre Urges States To Enforce Clinical Establishments Act & Standardise Hospital Rates

Centre Urges States To Enforce Clinical Establishments Act & Standardise Hospital Rates

Piramal, Ajinomoto team on ADC development and manufacturing

Piramal, Ajinomoto team on ADC development and manufacturing

Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid

Aurobindo Pharma Gets USFDA Nod for Glycerol Liquid